The Department of Health finds itself at the centre of a heated national debate. The controversy surrounds the recent R15.5bn AIDS drug tender. It has reignited a long-standing conflict between fiscal austerity and industrial growth. Should the state prioritise the lowest possible price, or should it pay a premium for local pharmaceutical manufacturing? The Tension Between Budget Cuts and Industrial…
Tag: manufacturing
-
Biovac R&D Lab to Drive Vaccine Manufacturing in Africa
State-backed vaccine manufacturer Biovac has officially launched a new product development laboratory at its Cape Town facility. This move strengthens its capacity to produce vaccines entirely on African soil, from start to finish. The new Biovac R&D lab in Pinelands, Cape Town, will enable scientists to conduct cutting-edge research and development (R&D) on the active pharmaceutical ingredients (APIs) for novel…
-
Aspen Unlocking Value with New Manufacturing Strategies
Aspen Pharmacare’s CEO, Stephen Saad, has declared that all hands are on deck to overhaul the group’s manufacturing business. He identified the performance of its sterile unit as a significant drag on earnings. This underperformance has caused the market to undervalue the company. This move is part of Aspen’s effort to unlock value for its stakeholders and enhance its market…
-
Adcock Ingram: A picture of resilience in a challenging market
Pharmaceutical stalwart Adcock Ingram presents a compelling case for investors seeking resilience amidst potential market turbulence. The group boasts a robust track record, with a mere 3% dip in headline earnings per share (HEPS) during the challenging Covid-impacted year of 2021. It was their worst annual performance in a decade. Since 2015, Adcock has delivered an impressive 16.2% compound annual…
-
Trump’s Pharmaceutical Tariffs to Boost US Manufacturing?
The Trump administration is preparing new trade measures. These plans could reshape the global drug industry. Trump’s pharmaceutical tariffs target imported medicines and their core ingredients. This follows the President’s “America First” agenda. He uses tariffs to protect American industries. These measures aim to help US manufacturing flourish. They also reduce dependency on other nations. The Goal Behind Trump’s Pharmaceutical…
-
Pharmaceutical industry fights to shield drugs from tariffs
Pharmaceutical giants are actively lobbying the Trump administration and European Union officials to exclude medical goods from escalating trade disputes. They fear significant price increases and restricted patient access to essential medications. The industry’s concerns centre on the potential impact of tariffs on top-selling drugs like Novo Nordisk’s Wegovy for weight loss and Merck’s cancer immunotherapy Keytruda. In discussions with…